Testing effectiveness (Phase 2)Study completedNCT00014677
What this trial is testing
NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
Who this might be right for
Brain and Central Nervous System Tumors
Neurocrine Biosciences